CSIRO research in biomaterials, pharmaceuticals and information and communication technologies (ICT) addresses the treatment needs within our community while delivering potential development opportunities in the healthcare and medical industries.
Providing advanced treatment options, in the form of medications, surgical procedures or patient management, have the potential to improve a person’s health and wellbeing. This can lead to faster recovery, better patient management and more active participation which all impact positively to reduce our national healthcare costs.
CSIRO’s strengths in treatment research include:
determining critical factors involved in diseases
design of specialised agents that target disease
advanced ICT to distil useful information from large data sets.
Some examples include the development of polymers and fabrics for injuries, devising the structure of viruses and development of treatments, such as RelenzaTM the first drug successful in treating influenza.